Launching the OncoLens Molecular and Rare Disease Tumor Board Series

We are excited to announce the launch of a monthly tumor board series focusing on the latest precision-medicine based and rare disease treatment protocols. These tumor boards will be led by a Key Opinion Leader and supported by a panel of experts to drive discussion alongside the audience Q&A.  Join us for this 30-minute webinar series that will help you stay up to date on the latest developments.

January Webinars

  • More information to come, stay tuned!


Stay Tuned for Future Webinars

Related Reading:

Four Factors Affecting the Post-COVID Cancer Care Landscape